Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Indo US Bio-Tech Debt & Borrowing

Indo Us Bio-Tech Ltd has confirmed that it does not fall under the 'Large Corporate' category for the financial year. This disclosure follows SEBI's framework for fund raising via debt securities. Consequently, the company is not subject to the mandatory incremental borrowing requirements applicable to large corporate entities.

Source

BSE filing, NSE: INDOUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Indo US Bio-Tech Ltd: key numbers

Share price
₹78.36
Market cap
₹157.1 Cr
Revenue (annual)
₹110.4 Cr
Net profit (annual)
₹13.12 Cr
P/E (TTM)
13.7×Sector 27.1×
Promoter holding
68.29%+0.00% QoQ
FII holding
0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Indo US Bio-Tech Ltd

All →

Other debt & borrowing announcements

All →